Bulbospinal muscular atrophy, often called Kennedy disease, is a rare genetic disorder that causes muscles to gradually weaken and waste away over time, mainly affecting adult men and progressing slowly across many decades.

What Is Bulbospinal Muscular Atrophy?

Bulbospinal muscular atrophy, also known as spinal and bulbar muscular atrophy or Kennedy disease, is a condition that affects specialized nerve cells responsible for controlling muscle movement. These nerve cells, called motor neurons, are located in the spinal cord and in a region of the brain called the brainstem. When these motor neurons gradually break down and die, the muscles they control become weaker and smaller over time.^[1]

The term “bulbar” refers to a bulb-shaped area in the lower part of the brain that contains nerve cells controlling muscles in the face, mouth, and throat. This is why people with this condition often experience difficulties with speaking and swallowing as the disease progresses. The condition was first described in 1968 by Dr. William Kennedy, which is why it bears his name.^[2]

Unlike many other forms of muscular atrophy that appear in childhood, bulbospinal muscular atrophy typically begins in adulthood. Most people start noticing symptoms between the ages of 30 and 50 years, though the disease can occasionally appear earlier or later in life. The progression is remarkably slow, unfolding over the course of decades rather than months or years.^[3]

How Common Is This Condition?

Bulbospinal muscular atrophy is considered a rare disease. The condition affects approximately one in every 30,000 to 40,000 males. Some estimates suggest it may affect as few as one in 150,000 males. The actual number of people living with this condition may be higher than reported because it can be mild in some individuals and may go undiagnosed or be mistaken for other conditions.^[3][4]

The disease has been reported across many different ethnic groups and geographical regions, including the United States, Europe, Japan, Australia, and Brazil. Some areas, such as western Finland and Japan, appear to have a higher concentration of cases, though the reasons for this are not entirely clear.^[5]

This condition almost exclusively affects males. Females can carry the genetic mutation that causes the disease, but they rarely develop symptoms. On the very rare occasions when women do experience symptoms, they are typically much milder than those seen in men, often limited to muscle cramps and occasional tremors, particularly as they age beyond 60 or 70 years.^[2][8]

What Causes Bulbospinal Muscular Atrophy?

The disease is caused by a specific genetic mutation in the androgen receptor (AR) gene, which is located on the X chromosome. This gene normally provides instructions for making a protein called an androgen receptor, which helps cells process male hormones known as androgens, including testosterone.^[4]

The mutation involves an abnormal expansion of a DNA segment called a CAG triplet repeat. In people without the disease, this DNA segment is repeated up to about 36 times within the gene. In people with bulbospinal muscular atrophy, however, the CAG segment is repeated at least 38 times, and it can be repeated as many as 62 times. The more times this segment repeats, the more abnormal the resulting protein becomes.^[3][4]

This expanded repeat causes the androgen receptor protein to misfold and clump together inside cells, particularly in motor neurons. These clumps interfere with normal cell functions and eventually lead to the death of the nerve cells. Without healthy motor neurons to transmit signals from the brain and spinal cord to the muscles, those muscles can no longer contract properly, leading to the progressive weakness and wasting characteristic of the disease.^[3]

The mutated androgen receptor also doesn’t work properly in its normal role of processing male hormones. This loss of normal function explains why men with bulbospinal muscular atrophy sometimes develop signs of mild androgen insensitivity, such as breast tissue enlargement and reduced fertility.^[2]

Who Is at Risk?

Bulbospinal muscular atrophy is inherited in what geneticists call an X-linked recessive pattern. This means the faulty gene is located on the X chromosome. Because males have only one X chromosome (paired with a Y chromosome), inheriting just one copy of the mutated gene is enough to cause the disease. Males inherit their X chromosome from their mothers, so if a woman carries the mutation, each of her sons has a 50 percent chance of inheriting it and developing the disease.^[4]

Females have two X chromosomes. Even if a woman inherits the mutated gene on one X chromosome, the normal gene on her other X chromosome typically protects her from developing symptoms. These women are called carriers. Female carriers have a 50 percent chance of passing the mutation to each of their children—both sons and daughters. Sons who inherit the mutation will develop the disease, while daughters who inherit it will become carriers themselves.^[2]

An important characteristic of X-linked inheritance is that affected fathers cannot pass the condition directly to their sons. This is because fathers give their Y chromosome, not their X chromosome, to their sons. However, all daughters of an affected father will be carriers, as they must inherit their father’s X chromosome.^[4]

Recognizing the Symptoms

The symptoms of bulbospinal muscular atrophy typically begin subtly and progress very slowly. Many men first notice problems in their 30s, 40s, or 50s, though onset can occur as early as the mid-20s or as late as the 80s in rare cases.^[5][8]

Early signs often include muscle cramps, particularly in the legs, and involuntary muscle twitching called fasciculations. Many people also develop tremors, most commonly in the hands, but these can also affect the head, voice, and lower limbs. These tremors may appear up to ten years before noticeable muscle weakness develops.^[6]

As the disease progresses, weakness typically begins in muscles closest to the center of the body, such as those in the hips, thighs, shoulders, and upper arms. This makes activities like climbing stairs, getting up from a chair, or reaching overhead increasingly difficult. Many people notice difficulty walking and a tendency to fall more frequently. The weakness spreads slowly to other limb muscles over time.^[3][8]

Involvement of the bulbar muscles—those controlling the face, mouth, and throat—is a hallmark of this condition. This causes problems with speech, which may become slurred or difficult to understand (a condition called dysarthria). Swallowing also becomes progressively more difficult (dysphagia), and people may notice their jaw hanging open or their tongue appearing smaller and twitching. Chewing food thoroughly can become challenging.^[3]

About one to two decades after symptoms first appear, most people will experience noticeable muscle weakness and thinning in both their arms and legs. By 20 years after onset, roughly one-third of affected individuals require a wheelchair for mobility, though many others continue to walk with assistance.^[8]

Beyond the neurological symptoms, men with bulbospinal muscular atrophy may develop signs related to hormone processing problems. These can include gynecomastia (breast tissue enlargement), shrinking of the testicles (testicular atrophy), reduced fertility, and difficulties with sexual function. Some men also experience metabolic changes such as glucose intolerance, elevated cholesterol and triglycerides, and fatty liver disease.^[3][6]

In advanced stages, weakness of the breathing muscles can occur, though severe respiratory complications are uncommon. When swallowing difficulties become severe, there is a risk of food or liquid entering the lungs (aspiration), which can lead to pneumonia. This is one of the more serious potential complications of the disease.^[8]

Most people with bulbospinal muscular atrophy maintain normal intellectual function throughout their lives. The disease affects motor neurons, not the areas of the brain responsible for thinking, memory, and personality.^[3]

Can Bulbospinal Muscular Atrophy Be Prevented?

Because bulbospinal muscular atrophy is a genetic condition caused by an inherited mutation, there is currently no way to prevent the disease itself from developing in someone who has inherited the expanded CAG repeat. However, genetic counseling and testing can help families understand their risk and make informed decisions about family planning.^[2]

For women who are known carriers of the mutation, prenatal testing is available to determine whether a pregnancy is affected. This testing can be performed through procedures such as amniocentesis or chorionic villus sampling once the mutation has been identified in an affected family member. Genetic counselors can provide detailed information about these options and help families navigate the complex decisions involved.^[2]

Carrier testing is also available for at-risk female relatives of someone with bulbospinal muscular atrophy. About 50 percent of female carriers show subclinical signs of the condition if carefully examined, such as mild changes on muscle testing, though they typically don’t experience significant symptoms that affect daily life.^[5]

While the disease itself cannot be prevented, there are steps people with bulbospinal muscular atrophy can take to manage complications and maintain quality of life. These include working with physical therapists to maintain mobility, speech therapists to address swallowing and communication challenges, and respiratory specialists to monitor breathing function. Avoiding testosterone supplementation is important, as research suggests that increasing androgen levels may worsen the disease.^[2][10]

How the Body Changes in This Disease

Understanding what happens inside the body in bulbospinal muscular atrophy helps explain why symptoms develop and progress as they do. The fundamental problem lies in the motor neurons—the specialized nerve cells that act as messengers between the brain, spinal cord, and muscles.^[1]

Motor neurons are responsible for sending signals that tell muscles when and how to contract. They extend long fibers called axons from the spinal cord to connect with muscle fibers throughout the body. When a motor neuron is healthy, it can maintain these connections and keep the muscles it controls functioning properly.^[7]

In bulbospinal muscular atrophy, the mutated androgen receptor protein accumulates inside motor neurons and forms clumps or aggregates. These aggregates disrupt many normal cell processes. They interfere with how genetic information is read and used by the cell, affect the cell’s energy-producing structures called mitochondria, and disrupt the transport of important materials along the motor neuron’s long axon to the muscle. Over time, these disruptions cause the motor neuron to malfunction and eventually die.^[3][7]

As motor neurons die, the muscles they control lose their nerve supply, a process called denervation. Without nerve signals, muscles cannot contract effectively. They begin to shrink and waste away, a process called atrophy. This is why the condition is characterized by both weakness (from poor muscle function) and visible muscle wasting (from the shrinking of muscle tissue).^[3]

Recent research has revealed that the mutated androgen receptor also directly affects muscle cells themselves, not just the neurons that control them. The disease involves both the loss of motor neurons and direct skeletal muscle involvement, which together contribute to the progressive muscle weakness seen in patients.^[6]

The dependence on androgens is a unique feature of this disease. The toxic effects of the mutated androgen receptor protein are triggered when it binds to testosterone and related hormones. This is why the disease primarily affects males, who have much higher levels of these hormones than females. It also explains why symptoms typically don’t appear until after puberty, when androgen levels rise significantly.^[7]

The slow progression of bulbospinal muscular atrophy—measured in decades rather than years—distinguishes it from many other motor neuron diseases. Muscle strength declines at a rate of approximately 2 percent per year based on quantitative assessments. This gradual pace means many people maintain significant function for many years after diagnosis.^[6]

The androgen insensitivity seen in many affected men results from the loss of normal androgen receptor function. Because the mutated receptor doesn’t process male hormones properly, the body responds as if androgen levels are lower than they actually are. This can lead to breast tissue development, testicular changes, and fertility problems. Blood tests often show elevated levels of certain hormones as the body tries to compensate for the receptor’s poor function.^[3]